chr5-78885583-C-A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The ENST00000565165.2(ARSB):c.1143G>T(p.Arg381Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R381R) has been classified as Pathogenic.
Frequency
Consequence
ENST00000565165.2 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 6Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000565165.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSB | NM_000046.5 | MANE Select | c.1142+1G>T | splice_donor intron | N/A | NP_000037.2 | |||
| ARSB | NM_198709.3 | c.1142+1G>T | splice_donor intron | N/A | NP_942002.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSB | ENST00000565165.2 | TSL:1 | c.1143G>T | p.Arg381Ser | missense | Exon 5 of 5 | ENSP00000456339.2 | ||
| ARSB | ENST00000264914.10 | TSL:1 MANE Select | c.1142+1G>T | splice_donor intron | N/A | ENSP00000264914.4 | |||
| ARSB | ENST00000396151.7 | TSL:1 | c.1142+1G>T | splice_donor intron | N/A | ENSP00000379455.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 6 Pathogenic:2
Splicing variant in canonical site (PVS1); In vitro functional studies supportive of a damaging effect on the gene product (low to no ARSB activity in homozygotes; PS3)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at